BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 12424611)

  • 1. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.
    Duan W; Gabril MY; Moussa M; Chan FL; Sakai H; Fong G; Xuan JW
    Oncogene; 2005 Feb; 24(9):1510-24. PubMed ID: 15674347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse PSP94 expression is prostate tissue-specific as demonstrated by a comparison of multiple antibodies against recombinant proteins.
    Thota A; Karajgikar M; Duan W; Gabril MY; Chan FL; Wong YC; Sakai H; Chin JL; Moussa M; Xuan JW
    J Cell Biochem; 2003 Apr; 88(5):999-1011. PubMed ID: 12616537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of initiation of angiogenesis in early stages of prostate adenocarcinoma development and progression in a transgenic murine model.
    Gabril M; Xuan J; Moussa M; Dinney CP; Chin JL; Izawa JI
    Urology; 2004 Dec; 64(6):1233-7. PubMed ID: 15596214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H
    Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies.
    Gabril MY; Duan W; Wu G; Moussa M; Izawa JI; Panchal CJ; Sakai H; Xuan JW
    Mol Ther; 2005 Mar; 11(3):348-62. PubMed ID: 15727931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chick delta1-crystallin enhancer influences mouse alphaA-crystallin promoter activity in transgenic mice.
    Reneker LW; Chen Q; Bloch A; Xie L; Schuster G; Overbeek PA
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4083-90. PubMed ID: 15505059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.
    Song Z; Wu X; Powell WC; Cardiff RD; Cohen MB; Tin RT; Matusik RJ; Miller GJ; Roy-Burman P
    Cancer Res; 2002 Sep; 62(17):5096-105. PubMed ID: 12208767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
    Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C
    Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
    J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
    Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST-PSP94.
    Kwong J; Chan FL; Jiang S; Guo Y; Imasato Y; Sakai H; Koropatnick J; Chin JL; Xuan JW
    J Cell Biochem; 1999 Sep; 74(3):406-17. PubMed ID: 10412042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific targeting using PSA promoter-based lentiviral vectors.
    Yu D; Chen D; Chiu C; Razmazma B; Chow YH; Pang S
    Cancer Gene Ther; 2001 Sep; 8(9):628-35. PubMed ID: 11593331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.